Cargando…

Plasma Lipidomic Patterns in Patients with Symptomatic Coronary Microvascular Dysfunction

Coronary microvascular dysfunction (MVD) is a syndrome of abnormal regulation of vascular tone, particularly during increased metabolic demand. While there are several risk factors for MVD, some of which are similar to those for coronary artery disease (CAD), the cause of MVD is not understood. We h...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindner, Jonathan R., Davidson, Brian P., Song, Zifeng, Maier, Claudia S., Minnier, Jessica, Stevens, Jan Frederick, Ferencik, Maros, Taqui, Sahar, Belcik, J. Todd, Moccetti, Federico, Layoun, Michael, Spellman, Paul, Turker, Mitchell S., Tavori, Hagai, Fazio, Sergio, Raber, Jacob, Bobe, Gerd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540191/
https://www.ncbi.nlm.nih.gov/pubmed/34677363
http://dx.doi.org/10.3390/metabo11100648
_version_ 1784588927532793856
author Lindner, Jonathan R.
Davidson, Brian P.
Song, Zifeng
Maier, Claudia S.
Minnier, Jessica
Stevens, Jan Frederick
Ferencik, Maros
Taqui, Sahar
Belcik, J. Todd
Moccetti, Federico
Layoun, Michael
Spellman, Paul
Turker, Mitchell S.
Tavori, Hagai
Fazio, Sergio
Raber, Jacob
Bobe, Gerd
author_facet Lindner, Jonathan R.
Davidson, Brian P.
Song, Zifeng
Maier, Claudia S.
Minnier, Jessica
Stevens, Jan Frederick
Ferencik, Maros
Taqui, Sahar
Belcik, J. Todd
Moccetti, Federico
Layoun, Michael
Spellman, Paul
Turker, Mitchell S.
Tavori, Hagai
Fazio, Sergio
Raber, Jacob
Bobe, Gerd
author_sort Lindner, Jonathan R.
collection PubMed
description Coronary microvascular dysfunction (MVD) is a syndrome of abnormal regulation of vascular tone, particularly during increased metabolic demand. While there are several risk factors for MVD, some of which are similar to those for coronary artery disease (CAD), the cause of MVD is not understood. We hypothesized that MVD in symptomatic non-elderly subjects would be characterized by specific lipidomic profiles. Subjects (n = 20) aged 35–60 years and referred for computed tomography coronary angiography (CTA) for chest pain but who lacked obstructive CAD (>50% stenosis), underwent quantitative regadenoson stress-rest myocardial contrast echocardiography (MCE) perfusion imaging for MVD assessment. The presence of MVD defined by kinetic analysis of MCE data was correlated with lipidomic profiles in plasma measured by liquid chromatography and high-resolution mass spectrometry. Nine of twenty subjects had evidence of MVD, defined by reduced hyperemic perfusion versus other subjects (beta-value 1.62 ± 0.44 vs. 2.63 ± 0.99 s(−1), p = 0.009). Neither the presence of high-risk but non-obstructive CAD on CTA, nor CAD risk factors were different for those with versus without MVD. Lipidomic analysis revealed that patients with MVD had lower concentrations of long-carbon chain triacylglycerols and diacylglycerols, and higher concentrations of short-chain triacylglycerols. The diacylglycerol containing stearic and linoleic acid classified all participants correctly. We conclude that specific lipidomic plasma profiles occur in MVD involving saturated long-chain fatty acid-containing acylglycerols that are distinctly different from those in non-obstructive CAD. These patterns could be used to better characterize the pathobiology and potential treatments for this condition.
format Online
Article
Text
id pubmed-8540191
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85401912021-10-24 Plasma Lipidomic Patterns in Patients with Symptomatic Coronary Microvascular Dysfunction Lindner, Jonathan R. Davidson, Brian P. Song, Zifeng Maier, Claudia S. Minnier, Jessica Stevens, Jan Frederick Ferencik, Maros Taqui, Sahar Belcik, J. Todd Moccetti, Federico Layoun, Michael Spellman, Paul Turker, Mitchell S. Tavori, Hagai Fazio, Sergio Raber, Jacob Bobe, Gerd Metabolites Article Coronary microvascular dysfunction (MVD) is a syndrome of abnormal regulation of vascular tone, particularly during increased metabolic demand. While there are several risk factors for MVD, some of which are similar to those for coronary artery disease (CAD), the cause of MVD is not understood. We hypothesized that MVD in symptomatic non-elderly subjects would be characterized by specific lipidomic profiles. Subjects (n = 20) aged 35–60 years and referred for computed tomography coronary angiography (CTA) for chest pain but who lacked obstructive CAD (>50% stenosis), underwent quantitative regadenoson stress-rest myocardial contrast echocardiography (MCE) perfusion imaging for MVD assessment. The presence of MVD defined by kinetic analysis of MCE data was correlated with lipidomic profiles in plasma measured by liquid chromatography and high-resolution mass spectrometry. Nine of twenty subjects had evidence of MVD, defined by reduced hyperemic perfusion versus other subjects (beta-value 1.62 ± 0.44 vs. 2.63 ± 0.99 s(−1), p = 0.009). Neither the presence of high-risk but non-obstructive CAD on CTA, nor CAD risk factors were different for those with versus without MVD. Lipidomic analysis revealed that patients with MVD had lower concentrations of long-carbon chain triacylglycerols and diacylglycerols, and higher concentrations of short-chain triacylglycerols. The diacylglycerol containing stearic and linoleic acid classified all participants correctly. We conclude that specific lipidomic plasma profiles occur in MVD involving saturated long-chain fatty acid-containing acylglycerols that are distinctly different from those in non-obstructive CAD. These patterns could be used to better characterize the pathobiology and potential treatments for this condition. MDPI 2021-09-22 /pmc/articles/PMC8540191/ /pubmed/34677363 http://dx.doi.org/10.3390/metabo11100648 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lindner, Jonathan R.
Davidson, Brian P.
Song, Zifeng
Maier, Claudia S.
Minnier, Jessica
Stevens, Jan Frederick
Ferencik, Maros
Taqui, Sahar
Belcik, J. Todd
Moccetti, Federico
Layoun, Michael
Spellman, Paul
Turker, Mitchell S.
Tavori, Hagai
Fazio, Sergio
Raber, Jacob
Bobe, Gerd
Plasma Lipidomic Patterns in Patients with Symptomatic Coronary Microvascular Dysfunction
title Plasma Lipidomic Patterns in Patients with Symptomatic Coronary Microvascular Dysfunction
title_full Plasma Lipidomic Patterns in Patients with Symptomatic Coronary Microvascular Dysfunction
title_fullStr Plasma Lipidomic Patterns in Patients with Symptomatic Coronary Microvascular Dysfunction
title_full_unstemmed Plasma Lipidomic Patterns in Patients with Symptomatic Coronary Microvascular Dysfunction
title_short Plasma Lipidomic Patterns in Patients with Symptomatic Coronary Microvascular Dysfunction
title_sort plasma lipidomic patterns in patients with symptomatic coronary microvascular dysfunction
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540191/
https://www.ncbi.nlm.nih.gov/pubmed/34677363
http://dx.doi.org/10.3390/metabo11100648
work_keys_str_mv AT lindnerjonathanr plasmalipidomicpatternsinpatientswithsymptomaticcoronarymicrovasculardysfunction
AT davidsonbrianp plasmalipidomicpatternsinpatientswithsymptomaticcoronarymicrovasculardysfunction
AT songzifeng plasmalipidomicpatternsinpatientswithsymptomaticcoronarymicrovasculardysfunction
AT maierclaudias plasmalipidomicpatternsinpatientswithsymptomaticcoronarymicrovasculardysfunction
AT minnierjessica plasmalipidomicpatternsinpatientswithsymptomaticcoronarymicrovasculardysfunction
AT stevensjanfrederick plasmalipidomicpatternsinpatientswithsymptomaticcoronarymicrovasculardysfunction
AT ferencikmaros plasmalipidomicpatternsinpatientswithsymptomaticcoronarymicrovasculardysfunction
AT taquisahar plasmalipidomicpatternsinpatientswithsymptomaticcoronarymicrovasculardysfunction
AT belcikjtodd plasmalipidomicpatternsinpatientswithsymptomaticcoronarymicrovasculardysfunction
AT moccettifederico plasmalipidomicpatternsinpatientswithsymptomaticcoronarymicrovasculardysfunction
AT layounmichael plasmalipidomicpatternsinpatientswithsymptomaticcoronarymicrovasculardysfunction
AT spellmanpaul plasmalipidomicpatternsinpatientswithsymptomaticcoronarymicrovasculardysfunction
AT turkermitchells plasmalipidomicpatternsinpatientswithsymptomaticcoronarymicrovasculardysfunction
AT tavorihagai plasmalipidomicpatternsinpatientswithsymptomaticcoronarymicrovasculardysfunction
AT faziosergio plasmalipidomicpatternsinpatientswithsymptomaticcoronarymicrovasculardysfunction
AT raberjacob plasmalipidomicpatternsinpatientswithsymptomaticcoronarymicrovasculardysfunction
AT bobegerd plasmalipidomicpatternsinpatientswithsymptomaticcoronarymicrovasculardysfunction